Delivery Order SPE2DB22D6029-SPE2DB24FU2AN

Award Date 8/9/24
Potential Completion Date 8/30/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,918.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GAMUNEX-C 5 gram/50 ml vials. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award, valued at $3,036.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 5 gram/50 mL vials, a specialty medical product. It has an ultimate completion date of February 27, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GAMUNEX-C 10 gram/100 ml vials. The $3,606.84 firm-fixed-price delivery order has a completion date of November 20, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $51,945.36, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a critical medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 1 gram/10 ml vials. The Delivery Order, valued at $4,808.80, is a Firm Fixed Price contract with an ultimate completion date of October 7, 2024. AmerisourceBergen, through its Corporate Office Division, will provide these critical medical supplies to support various government agencies and healthcare programs, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $12,324.10 firm-fixed-price delivery order is for GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with a completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,895.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 1 GRAM/10 ML VIAL 10ML, a medical product, and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of February 3, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
This federal contract award, valued at $3,662.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product, to support federal healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, a pharmaceutical product. The contract has a firm fixed price of $18,034.20 and a period of performance through October 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities,...
This federal contract award, valued at $3,731.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product used in healthcare settings. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FU2AN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of GAMUNEX-C 5 GRAM/50 ML VIAL 50ML. The contract is a Firm Fixed Price Delivery Order valued at $3,551.16 with an ultimate completion date of August 30, 2024. Amerisourcebergen, the prime contractor, has been awarded this contract to supply this critical medical product to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. The contract is not designated as a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for providing a comprehensive range of pharmaceutical and medical supplies to federal agencies and healthcare providers.

Generated 11/8/24, 9:23 AM